BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32078010)

  • 21. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
    Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
    Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common fetal hemoglobin variants in Lebanese patients bearing the codon 29 beta gene mutation associated with different thalassemia phenotypes.
    Brancaleoni V; Moukhadder HM; Consonni D; Koussa S; Di Pierro E; Cappellini MD; Taher A
    Ann Hematol; 2019 Apr; 98(4):833-840. PubMed ID: 30506348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Swiss-type heterocellular HPFH from XmnI-Gγ and HBBP1 polymorphisms on HbF, HbE, MCV and MCH levels in Thai HbE carriers.
    Kerdpoo S; Limweeraprajak E; Tatu T
    Int J Hematol; 2014 Mar; 99(3):338-44. PubMed ID: 24474642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is hemoglobin instability important in the interaction between hemoglobin E and beta thalassemia?
    Rees DC; Clegg JB; Weatherall DJ
    Blood; 1998 Sep; 92(6):2141-6. PubMed ID: 9731073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of candidate modifier polymorphisms in Hb E-beta 0-thalassemia patients.
    Sripichai O; Whitacre J; Munkongdee T; Kumkhaek C; Makarasara W; Winichagoon P; Abel K; Braun A; Fucharoen S
    Ann N Y Acad Sci; 2005; 1054():433-8. PubMed ID: 16339693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Understanding of Non-Transfusion-Dependent Thalassemia Associated with Hemoglobin E-β-Thalassemia in Northeast Thailand.
    Yamsri S; Pakdee N; Fucharoen G; Sanchaisuriya K; Fucharoen S
    Acta Haematol; 2016; 136(4):233-239. PubMed ID: 27710960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineered U7 snRNA mediates sustained splicing correction in erythroid cells from β-thalassemia/HbE patients.
    Preedagasamzin S; Nualkaew T; Pongrujikorn T; Jinawath N; Kole R; Fucharoen S; Jearawiriyapaisarn N; Svasti S
    Biochem Biophys Res Commun; 2018 Apr; 499(1):86-92. PubMed ID: 29550480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The correlation of α-globin gene mutations and the XmnI polymorphism with clinical severity of Hb E/β-thalassemia.
    Charoenkwan P; Teerachaimahit P; Sanguansermsri T
    Hemoglobin; 2014; 38(5):335-8. PubMed ID: 25238043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Gγ-158(C→T) polymorphism in hemoglobin E/β-thalassemia major in Southern China.
    Liu RR; Wang MY; Lai YR
    J Hematol Oncol; 2010 Sep; 3():29. PubMed ID: 20822527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple non radioactive method for detecting beta-thalassemia/hbe disease: application to prenatal diagnosis.
    Fucharoen S; Fucharoen G; Ratanasiri T; Jetsrisuparb A; Fukumaki Y
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():278-81. PubMed ID: 8629124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and hematological phenotype of homozygous hemoglobin E: revisit of a benign condition with hidden reproductive risk.
    Tachavanich K; Viprakasit V; Chinchang W; Glomglao W; Pung-Amritt P; Tanphaichitr VS
    Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):306-16. PubMed ID: 19323016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hemoglobin E thalassemias.
    Fucharoen S; Weatherall DJ
    Cold Spring Harb Perspect Med; 2012 Aug; 2(8):. PubMed ID: 22908199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemoglobin E-beta thalassemia: factors affecting phenotype.
    Panigrahi I; Agarwal S; Gupta T; Singhal P; Pradhan M
    Indian Pediatr; 2005 Apr; 42(4):357-62. PubMed ID: 15876597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of the Degree of Erythroid Expansion and Maturation Arrest with the Clinical Severity of β0-Thalassemia/Hemoglobin E Patients.
    Suriyun T; Kaewsakulthong W; Khamphikham P; Chumchuen S; Hongeng S; Fucharoen S; Sripichai O
    Acta Haematol; 2021; 144(6):660-671. PubMed ID: 34535581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidant in plasma of hemoglobin-E trait.
    Palasuwan A; Kittisakulrat T; Amornrit W; Soogarun S; Wiwanitkit V; Pradniwat P
    Southeast Asian J Trop Med Public Health; 2005; 36 Suppl 4():271-3. PubMed ID: 16438222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemoglobin E disease in North Indian population: a report of 11 cases.
    Kishore B; Khare P; Gupta RJ; Bisht S; Majumdar K
    Hematology; 2007 Aug; 12(4):343-7. PubMed ID: 17654063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of β-Thalassemia and hemoglobin E in two migrant populations of Manipur, North East India.
    Achoubi N; Asghar M; Saraswathy KN; Murry B
    Genet Test Mol Biomarkers; 2012 Oct; 16(10):1195-200. PubMed ID: 23057593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb E-beta-thalassemia in Northeast Thailand.
    Nuntakarn L; Fucharoen S; Fucharoen G; Sanchaisuriya K; Jetsrisuparb A; Wiangnon S
    Blood Cells Mol Dis; 2009; 42(1):32-5. PubMed ID: 18951049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular basis of HbE-beta-thalassemia and the origin of HbE in northeast Thailand: identification of one novel mutation using amplified DNA from buffy coat specimens.
    Fucharoen G; Fucharoen S; Jetsrisuparb A; Fukumaki Y
    Biochem Biophys Res Commun; 1990 Jul; 170(2):698-704. PubMed ID: 1974422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular understanding of Indian untransfused thalassemia intermedia.
    Nadkarni A; Dabke P; Colah R; Ghosh K
    Int J Lab Hematol; 2015 Dec; 37(6):791-6. PubMed ID: 26226914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.